Literature DB >> 21250837

Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.

Liisa K Selin1, Myriam F Wlodarczyk, Anke R Kraft, Siwei Nie, Laurie L Kenney, Roberto Puzone, Franco Celada.   

Abstract

Heterologous immunity is a common phenomenon present in all infections. Most of the time it is beneficial, mediating protective immunity, but in some individuals that have the wrong crossreactive response it leads to a cascade of events that result in severe immunopathology. Infections have been associated with autoimmune diseases such as diabetes, multiple sclerosis and lupus erythematosis, but also with unusual autoimmune like pathologies where the immune system appears dysregulated, such as, sarcoidosis, colitis, panniculitis, bronchiolitis obliterans, infectious mononucleosis and even chronic fatigue syndrome. Here we review the evidence that to better understand these autoreactive pathologies it requires an evaluation of how T cells are regulated and evolve during sequential infections with different pathogens under the influence of heterologous immunity.

Entities:  

Mesh:

Year:  2011        PMID: 21250837      PMCID: PMC3633594          DOI: 10.3109/08916934.2011.523277

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  167 in total

1.  Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.

Authors:  W Chen; L C Antón; J R Bennink; J W Yewdell
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

Review 2.  Immunological memory and protective immunity: understanding their relation.

Authors:  R Ahmed; D Gray
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

3.  Virus-induced polyclonal cytotoxic T lymphocyte stimulation.

Authors:  H Y Yang; P L Dundon; S R Nahill; R M Welsh
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

Review 4.  No one is naive: the significance of heterologous T-cell immunity.

Authors:  Raymond M Welsh; Liisa K Selin
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

5.  Brachial plexus neuritis following HPV vaccination.

Authors:  Ph Debeer; P De Munter; F Bruyninckx; R Devlieger
Journal:  Vaccine       Date:  2008-07-03       Impact factor: 3.641

6.  Quadrivalent Human Papillomavirus recombinant vaccine associated lipoatrophy.

Authors:  Samar Ojaimi; Jim P Buttery; Tony M Korman
Journal:  Vaccine       Date:  2009-06-23       Impact factor: 3.641

7.  Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease.

Authors:  C F Evans; M S Horwitz; M V Hobbs; M B Oldstone
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

8.  CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.

Authors:  P Borrow; A Tishon; S Lee; J Xu; I S Grewal; M B Oldstone; R A Flavell
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

9.  Cross-reactivity between HLA-A2-restricted FLU-M1:58-66 and HIV p17 GAG:77-85 epitopes in HIV-infected and uninfected individuals.

Authors:  Paula M Acierno; Danforth A Newton; Edwin A Brown; Lou Anne Maes; John E Baatz; Sebastiano Gattoni-Celli
Journal:  J Transl Med       Date:  2003-08-14       Impact factor: 5.531

Review 10.  Molecular mimicry in multiple sclerosis.

Authors:  Jane E Libbey; Lori L McCoy; Robert S Fujinami
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

View more
  23 in total

Review 1.  Computer simulations of heterologous immunity: highlights of an interdisciplinary cooperation.

Authors:  Claudia Calcagno; Roberto Puzone; Yanthe E Pearson; Yiming Cheng; Dario Ghersi; Liisa K Selin; Raymond M Welsh; Franco Celada
Journal:  Autoimmunity       Date:  2011-01-27       Impact factor: 2.815

Review 2.  Autoimmunity in 2011.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

Review 3.  Adaptation in the innate immune system and heterologous innate immunity.

Authors:  Stefan F Martin
Journal:  Cell Mol Life Sci       Date:  2014-07-06       Impact factor: 9.261

4.  Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct αβT Cell Receptor Signatures.

Authors:  Emma J Grant; Tracy M Josephs; Sophie A Valkenburg; Linda Wooldridge; Margaret Hellard; Jamie Rossjohn; Mandvi Bharadwaj; Katherine Kedzierska; Stephanie Gras
Journal:  J Biol Chem       Date:  2016-09-19       Impact factor: 5.157

5.  Identification of three novel CTL epitopes within nucleocapsid protein of Hantaan virus.

Authors:  Meiliang Wang; Yong Zhu; Jiuping Wang; Tongde Lv; Boquan Jin
Journal:  Viral Immunol       Date:  2011-11-23       Impact factor: 2.257

Review 6.  Vaccination and heterologous immunity: educating the immune system.

Authors:  Anna Gil; Laurie L Kenney; Rabinarayan Mishra; Levi B Watkin; Nuray Aslan; Liisa K Selin
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-01       Impact factor: 2.184

7.  Alpha beta-crystallin expression and presentation following infection with murine gammaherpesvirus 68.

Authors:  Vinita S Chauhan; Daniel A Nelson; Ian Marriott; Kenneth L Bost
Journal:  Autoimmunity       Date:  2013-04-16       Impact factor: 2.815

Review 8.  Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful.

Authors:  K Kai McKinstry; Richard W Dutton; Susan L Swain; Tara M Strutt
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-05-25       Impact factor: 4.291

9.  Increased Immune Response Variability during Simultaneous Viral Coinfection Leads to Unpredictability in CD8 T Cell Immunity and Pathogenesis.

Authors:  Laurie L Kenney; Markus Cornberg; Alex T Chen; Sebastien Emonet; Juan Carlos de la Torre; Liisa K Selin
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

Review 10.  Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms.

Authors:  K L Flanagan; R van Crevel; N Curtis; F Shann; O Levy
Journal:  Clin Infect Dis       Date:  2013-04-09       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.